Filing Details

Accession Number:
0001209191-23-024264
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-14 06:00:16
Reporting Period:
2023-04-12
Accepted Time:
2023-04-14 06:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Oncternal Therapeutics Inc. ONCT Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777467 C. Chase Leavitt 12230 El Camino Real, Suite 230
San Diego CA 92130
General Counsel/Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-12 15,000 $0.29 96,901 No 4 P Direct
Common Stock Acquisiton 2023-04-13 10,000 $0.29 106,901 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct